Platelet mitochondrial DNA methylation: A potential new marker of cardiovascular disease

Clinical Epigenetics

Volumn 7, Issue 1, 2015, Pages

  Baccarelli, Andrea A ^a   Byun, Hyang Min ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Cardiovascular disease; DNA methylation; Mitochondrial epigenetics; Platelet

Indexed keywords

ACETYLSALICYLIC ACID; AMLODIPINE BESYLATE; ATENOLOL PLUS CHLORTALIDONE; ATORVASTATIN; CARVEDILOL; CITRATE POTASSIUM; CYTOCHROME C OXIDASE; DEXAMETHASONE; DOXAZOSIN; EZETIMIBE PLUS SIMVASTATIN; HYDROCHLOROTHIAZIDE; HYDROCHLOROTHIAZIDE PLUS LOSARTAN; HYDROCHLOROTHIAZIDE PLUS VALSARTAN; LEUCINE TRANSFER RNA LIGASE; LEVETIRACETAM; LEVOTHYROXINE SODIUM; LISINOPRIL; METOPROLOL SUCCINATE; MITOCHONDRIAL DNA; NAPROXEN; OMEGA 3 ACID ETHYL ESTER; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; RABEPRAZOLE; RAMIPRIL; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; SIMVASTATIN; TAMSULOSIN; UNINDEXED DRUG; VITAMIN D; WARFARIN;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIAGNOSTIC TEST ACCURACY STUDY; DNA METHYLATION; EPIGENETICS; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LUNG CANCER; MALE; MITOCHONDRIAL GENOME; MITOCHONDRION; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN METABOLISM; PYROSEQUENCING; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; THROMBOCYTE;

EID: 84983071823     PISSN: 18687075     EISSN: 18687083     Source Type: Journal    
DOI: 10.1186/s13148-015-0078-0     Document Type: Article

References (42)

1. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, et al. Heart disease and stroke statistics-2014 update: a report from the American Heart Association. Circulation. 2014;129(3):e28-292.
2. Brookmeyer R, Gray S, Kawas C. Projections of Alzheimer’s disease in the United States and the public health impact of delaying disease onset. Am J Public Health. 1998;88(9):1337-42.
3. Gregg D, Goldschmidt-Clermont PJ. Cardiology patient page. Platelets and cardiovascular disease. Circulation. 2003;108(13):e88-90.
4. Kottke-Marchant K. Importance of platelets and platelet response in acute coronary syndromes. Cleve Clin J Med. 2009;76 Suppl 1:S2-7.
5. Salky N, Dugdale M. Platelet abnormalities in ischemic heart disease. Am J Cardiol. 1973;32(5):612-7.
6. Willoughby S, Holmes A, Loscalzo J. Platelets and cardiovascular disease. Eur J Cardiovasc Nurs. 2002;1(4):273-88.
7. Akkerman JW. Regulation of carbohydrate metabolism in platelets: a review. Thromb Haemost. 1978;39(3):712-24.
8. Akkerman JW, Holmsen H, Loughnane M. Simultaneous measurement of aggregation, secretion, oxygen uptake, proton production, and intracellular metabolites in the same platelet suspension. Anal Biochem. 1979;97(2):387-93.
9. Akkerman JW, Holmsen H. Interrelationships among platelet responses: studies on the burst in proton liberation, lactate production, and oxygen uptake during platelet aggregation and Ca2+ secretion. Blood. 1981;57 (5):956-66.
10. Byun HM, Panni T, Motta V, Hou L, Nordio F, Apostoli P, et al. Effects of airborne pollutants on mitochondrial DNA methylation. Part Fibre Toxicol. 2013;10:18.
11. Byun HM, Baccarelli AA. Environmental exposure and mitochondrial epigenetics: study design and analytical challenges. Hum Genet. 2014;133(3):247-57.
12. Infantino V, Castegna A, Iacobazzi F, Spera I, Scala I, Andria G, et al. Impairment of methyl cycle affects mitochondrial methyl availability and glutathione level in Down’s syndrome. Mol Genet Metab. 2011;102(3):378-82.
13. Feng S, Xiong L, Ji Z, Cheng W, Yang H. Correlation between increased ND2 expression and demethylated displacement loop of mtDNA in colorectal cancer. Mol Med Rep. 2012;6(1):125-30.
14. Ramos A, Barbena E, Mateiu L, del Mar GM, Mairal Q, Lima M, et al. Nuclear insertions of mitochondrial origin: database updating and usefulness in cancer studies. Mitochondrion. 2011;11(6):946-53.
15. Vanyushin BF, Kiryanov GI, Kudryashova IB, Belozersky AN. DNA-methylase in loach embryos (Misgurnus fossilis). FEBS Lett. 1971;15(4):313-6.
16. Shock LS, Thakkar PV, Peterson EJ, Moran RG, Taylor SM. DNA methyltransferase 1, cytosine methylation, and cytosine hydroxymethylation in mammalian mitochondria. Proc Natl Acad Sci U S A. 2011;108(9):3630-5.
17. Iacobazzi V, Castegna A, Infantino V, Andria G. Mitochondrial DNA methylation as a next-generation biomarker and diagnostic tool. Mol Genet Metab. 2013;110(1-2):25-34.
18. Baccarelli A, Rienstra M, Benjamin EJ. Cardiovascular epigenetics: basic concepts and results from animal and human studies. Circ Cardiovasc Genet. 2010;3(6):567-73.
19. Baccarelli A, Wright R, Bollati V, Litonjua A, Zanobetti A, Tarantini L, et al. Ischemic heart disease and stroke in relation to blood DNA methylation. Epidemiology. 2010;21(6):819-28.
20. Castro R, Rivera I, Struys EA, Jansen EE, Ravasco P, Camilo ME, et al. Tavares de Almeida I: increased homocysteine and S-adenosylhomocysteine concentrations and DNA hypomethylation in vascular disease. Clin Chem. 2003;49(8):1292-6.
21. Kim M, Long TI, Arakawa K, Wang R, Yu MC, Laird PW. DNA methylation as a biomarker for cardiovascular disease risk. PLoS One. 2010;5(3), e9692.
22. Houseman A, Accomando P, Koestler C, Christensen C, Marsit J, Nelson H, et al. DNA methylation arrays as surrogate measures of cell mixture distribution. BMC Bioinformatics. 2012;13:86.
23. Jaffe AE, Irizarry RA. Accounting for cellular heterogeneity is critical in epigenome-wide association studies. Genome Biol. 2014;15(2):R31.
24. Waterhouse DF, Cahill RA, Sheehan F, McCreery C. Prediction of calculated future cardiovascular disease by monocyte count in an asymptomatic population. Vasc Health Risk Manag. 2008;4(1):177-87.
25. Maekawa M, Taniguchi T, Higashi H, Sugimura H, Sugano K, Kanno T. Methylation of mitochondrial DNA is not a useful marker for cancer detection. Clin Chem. 2004;50(8):1480-1.
26. Wong M, Gertz B, Chestnut BA, Martin LJ. Mitochondrial DNMT3A and DNA methylation in skeletal muscle and CNS of transgenic mouse models of ALS. Front Cell Neurosci. 2013;7:279.
27. Finsterer J. Genetic, pathogenetic, and phenotypic implications of the mitochondrial A3243G tRNALeu(UUR) mutation. Acta Neurol Scand. 2007;116(1):1-14.
28. Reardon W, Ross RJ, Sweeney MG, Luxon LM, Pembrey ME, Harding AE, et al. Diabetes mellitus associated with a pathogenic point mutation in mitochondrial DNA. Lancet. 1992;340(8832):1376-9.
29. Yasukawa T, Suzuki T, Ueda T, Ohta S, Watanabe K. Modification defect at anticodon wobble nucleotide of mitochondrial tRNAs(Leu)(UUR) with pathogenic mutations of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes. J Biol Chem. 2000;275(6):4251-7.
30. Xin M, Olson EN, Bassel-Duby R. Mending broken hearts: cardiac development as a basis for adult heart regeneration and repair. Nat Rev Mol Cell Biol. 2013;14(8):529-41.
31. Movassagh M, Choy MK, Goddard M, Bennett MR, Down TA, Foo RS. Differential DNA methylation correlates with differential expression of angiogenic factors in human heart failure. PLoS One. 2010;5(1), e8564.
32. Bauereisen E, Hauck G, Jacob R, Peiper U. Endhdiastolic pressure-volume relationships and the work diagram of the intact heart during natural circulation depending on heart frequency, adrenalin effect and vagus stimulation. Pflugers Arch Gesamte Physiol Menschen Tiere. 1964;281:216-30.
33. Griffiths EJ. Mitochondria and heart disease. Adv Exp Med Biol. 2012;942:249-67.
34. Pecina P, Houstkova H, Hansikova H, Zeman J, Houstek J. Genetic defects of cytochrome c oxidase assembly. Physiol Res. 2004;53 Suppl 1:S213-23.
35. Lorente L, Martin MM, Lopez-Gallardo E, Iceta R, Blanquer J, Sole-Violan J, et al. Higher platelet cytochrome oxidase specific activity in surviving than in non-surviving septic patients. Crit Care. 2014;18(3):R136.
36. Despres JP. Body fat distribution and risk of cardiovascular disease: an update. Circulation. 2012;126(10):1301-13.
37. Collins ML, Eng S, Hoh R, Hellerstein MK. Measurement of mitochondrial DNA synthesis in vivo using a stable isotope-mass spectrometric technique. J Appl Physiol (1985). 2003;94(6):2203-11.
38. Fukami MH, Salganicoff L. Isolation and properties of human platelet mitochondria. Blood. 1973;42(6):913-8.
39. Boudreau LH, Duchez AC, Cloutier N, Soulet D, Martin N, Bollinger J, et al. Platelets release mitochondria serving as substrate for bactericidal group IIA secreted phospholipase A2 to promote inflammation. Blood. 2014;124(14):2173-83.
40. Aquilano K, Vigilanza P, Baldelli S, Pagliei B, Rotilio G, Ciriolo MR. Peroxisome proliferator-activated receptor gamma co-activator 1alpha (PGC-1alpha) and sirtuin 1 (SIRT1) reside in mitochondria: possible direct function in mitochondrial biogenesis. J Biol Chem. 2010;285(28):21590-9.
41. Byun HM, Heo K, Mitchell KJ, Yang AS. Mono-allelic retrotransposon insertion addresses epigenetic transcriptional repression in human genome. J Biomed Sci. 2012;19:13.
42. Li LC, Dahiya R. MethPrimer: designing primers for methylation PCRs. Bioinformatics. 2002;18(11):1427-31.